AIMD Expanded Global Availability of A-LRYNGO Device
The AI-guided laryngoscope seeks to standardize intubation success by offering real-time glottis identification.
Updated on Sept. 22, 2026 in Artificial Intelligence
Live Poll
Do you support the integration of AI-guided tools into standard local emergency medical procedures?
AIMD Inc. has expanded the global distribution of its A-LRYNGO, an AI-guided video laryngoscope designed to minimize complications during airway management. The hardware is already deployed in public hospitals across Uzbekistan, Vietnam, and Laos, with current evaluations underway at the Mayo Clinic in the United States.
Why it matters
Endotracheal intubation success currently relies heavily on operator experience, yet failures or delays carry severe risks of hypoxia and cardiac arrest during the 100 million procedures performed annually. By automating glottis recognition, this hardware seeks to reduce the technical variability inherent in emergency airway management.
The A-LRYNGO platform features a startup time of five seconds and operates using on-device AI, eliminating the need for external servers or recurring software license fees.
The players
AIMD Inc.
A Seoul-based medical technology developer focused on AI-integrated diagnostics and hardware for critical care.
Mayo Clinic
A non-profit American academic medical center currently conducting clinical evaluations of the A-LRYNGO system.
The details
The device functions as an AI-guided video laryngoscope—a tool used to view the vocal cords during intubation—that utilizes onboard processing to identify the glottis in real time. This mechanism provides immediate visual guidance to the clinician, integrated with capabilities for wireless screen sharing, video recording, and image capture to assist in patient monitoring.
Timeline
September 18, 2026: AIMD showcased the device at the KOICA AI Partners' Fair.
September 22, 2026: The company announced the global expansion of A-LRYNGO.
November 2026: AIMD is scheduled to demonstrate the device at MEDICA 2026 in Düsseldorf.
The Tech Race
The move into U.S.-based testing at the Mayo Clinic marks a critical transition for the platform, which has established its initial footprint in public hospitals across Asia. This expansion pits the device against established surgical imaging incumbents that typically rely on centralized AI cloud processing.
The technology aims to assist clinicians in high-pressure emergency environments by providing reliable visual guidance, regardless of external network availability. Hospitals interested in the platform may monitor its upcoming performance demonstrations at MEDICA 2026.
The takeaway
The trajectory of this technology hinges on its ability to prove clinical efficacy in high-resource settings like the Mayo Clinic. Clinicians should watch for the performance results expected to be discussed at MEDICA 2026 in Düsseldorf this November.
Further reading
Learn more about the latest developments in Artificial Intelligence.
Live Poll
Do you support the integration of AI-guided tools into standard local emergency medical procedures?
